Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 407

The DOI matches its Crossref record; 117 of the 117 references it cites were found in a registry or an index.

The Systemic Inflammatory Response to Cardiopulmonary Bypass: Pathophysiological, Therapeutic, and Pharmacological Considerations

Hall, Richard I., Smith, Mark Stafford, Rocker, Graeme·1997·Anesthesia & Analgesia

Abstract

Cardiac surgery and cardiopulmonary bypass (CPB) activate a systemic inflammatory response characterized clinically by alterations in cardiovascular and pulmonary function. Significant morbidity is rare (approximately 1%-2% of cases), but when severe acute lung injury occurs, mortality is high (50%-70%) [1]. However, most patients undergoing CPB experience some degree of organ dysfunction as a result of activation of the inflammatory response. The purpose of this review is to examine the recent developments in our understanding of the pathophysiological mechanisms responsible for this response, the treatment modalities that have been used to ameliorate it, and the possible implications of these findings for the conduct of anesthesia for cardiac surgery. Pathophysiology Initiation of the Systemic Inflammatory Response The systemic inflammatory response may be initiated during cardiac surgery by a number of processes, including blood contact with the foreign surface of the CPB apparatus [2], development of ischemia and reperfusion injury [3], and presence of endotoxemia [4]. In the course of cardiac surgery using CPB, all three processes (i.e., blood contact activation, ischemia and reperfusion injury, and endotoxemia) are present and contribute concurrently to the humoral and cellular development of the processes leading to the systemic inflammatory response (Figure 1). The extent and duration of the response is influenced by many factors, including the pharmacological agents used to ameliorate the response [3,5-36] (see Table 1, Table 3, and Table 4 and the discussion in the section on therapeutic strategies) (pharmacological), the composition of the priming solution [37-39], the presence of pulsatile perfusion [40,41], the use of mechanical filtration [42-47], the type of oxygenator [6,7,40,42,48-55], the type of extracorporeal circuit [56-64], and the temperature during CPB [6,7,37-44,46-50,52-70] (see Table 2 and Table 5 and the discussion in the section on therapeutic strategies) (mechanical) [4,66-71]. Excellent reviews of the role of complement activation [72] and the effects of ischemia-reperfusion [73,74] have been published previously. We have chosen in this review to focus on the roles of endotoxin release and initiation of cytokine activation, mechanisms that have been relatively recently elucidated.Figure 1: Pathways leading to activation of the systemic inflammatory response syndrome (SIRS) and sites of therapeutic intervention. Therapeutic interventions: 1 = mechanical factors, 2 = glucocorticoids, 3 = pentoxyphylline, 4 = protease inhibitors, 5 = gut therapy. TNF alpha = tumor necrosis factor alpha, IL = interleukin, CPB = cardiopulmonary bypass, DIC = disseminated intravascular coagulation.Table 1: Randomized Trials of Pharmacological Interventions Designed to Reduce the Systemic Inflammatory Response That Occur During Cardiac SurgeryTable 3: Table 1 (Continued)Table 4: Table 1 (Continued)Table 2: Randomized Trials of Mechanical Strategies to Reduce the Systemic Inflammatory Response During Cardiac SurgeryTable 5: Table 2 (Continued)Increased concentrations of endotoxin, a lipopolysaccharide associated with cell membranes of Gramnegative microorganisms (Figure 2), have been measured in plasma during CPB [4,9,13,15,29,30,75,76]. The source and significance of these increases are currently debated. A reduction in splanchnic blood flow has been observed during CPB [77]. It has been hypothesized that this may be associated with the subsequent translocation of endotoxin across the ischemic gut wall, with activation of the systemic inflammatory response [73]. Increased levels of endotoxin have been measured in venous blood from the splanchnic vascular bed during CPB [78], and levels of endotoxin are correlated with the degree of hemodynamic compromise and aortic cross-clamp time (i.e., duration of relative ischemia) during cardiac surgery [75]. Furthermore, sequential elevation of endotoxin followed by increased levels of inflammatory cytokines has been observed [79], and in the elderly, the degree of myocardial dysfunction after CPB correlates with the level of endotoxin measured [80]. Finally, studies of treatments designed to reduce gut endotoxin levels [29,30] or to improve gut perfusion [76] show some efficacy. On the other hand, there have been disturbing inconsistencies in the studies of the role of endotoxin in relation to cardiac surgery and CPB. Investigators have measured endotoxin levels in a variety of fluids other than blood, including the CPB priming fluid and the intravenous solutions used before initiating CPB [81]. In some studies, investigators have been unable to measure increases in endotoxin levels at any time during CPB [82] or to correlate measured levels with organ dysfunction [83]. There have also been problems with the sensitivity and specificity of the endotoxin assay used in some studies [15]. Despite these difficulties, we believe that current data suggest that the ph

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1097/00000539-199710000-00011

Cites

117 of 117 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

1 retracted

Show all 117 references

Cited by

See all 407

Metadata

Authors
Hall, R. I., Smith, M. S., & Rocker, G.
Venue
Anesthesia & Analgesia
Published
1997-10
Volume
85
Issue
4
Pages
766-782
ISSN
0003-2999 (ISSN-L)
OpenAlex
W2087467622
Cited by
407
References
117
FWCI
14.21
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: The Systemic Inflammatory Response to Cardiopulmonary Bypass: Pathophysiological, Therapeutic, and Pharmacological Considerations. https://app.cochat.ai/papers/10.1097/00000539-199710000-00011
The paper
Hall, R. I., Smith, M. S., & Rocker, G. (1997). The Systemic Inflammatory Response to Cardiopulmonary Bypass: Pathophysiological, Therapeutic, and Pharmacological Considerations. Anesthesia & Analgesia. https://doi.org/10.1097/00000539-199710000-00011

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.